 Amy MacRitchie
Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase | 4 | 2001 | 237 | 0.360 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2007 | 23 | 0.270 |
Why?
| | Endothelium, Vascular | 4 | 2001 | 901 | 0.240 |
Why?
| | Pulmonary Circulation | 2 | 2001 | 430 | 0.170 |
Why?
| | Respiratory Insufficiency | 1 | 2001 | 313 | 0.140 |
Why?
| | Estradiol | 1 | 1997 | 494 | 0.110 |
Why?
| | Sheep | 5 | 2001 | 837 | 0.090 |
Why?
| | Vascular Resistance | 2 | 2001 | 371 | 0.080 |
Why?
| | Peroxynitrous Acid | 1 | 2007 | 14 | 0.070 |
Why?
| | Phospholipases A2 | 1 | 2007 | 79 | 0.070 |
Why?
| | Immunohistochemistry | 3 | 2001 | 1698 | 0.070 |
Why?
| | Phospholipases A | 1 | 2007 | 99 | 0.070 |
Why?
| | COS Cells | 1 | 2007 | 185 | 0.070 |
Why?
| | Oxidants | 1 | 2007 | 109 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 1998 | 287 | 0.060 |
Why?
| | Tyrosine | 1 | 2007 | 223 | 0.060 |
Why?
| | Lipoproteins | 1 | 2007 | 171 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 3 | 2001 | 203 | 0.060 |
Why?
| | Phospholipids | 1 | 2007 | 215 | 0.060 |
Why?
| | Pulmonary Artery | 3 | 1999 | 1096 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2007 | 596 | 0.050 |
Why?
| | Animals, Newborn | 3 | 2001 | 835 | 0.050 |
Why?
| | Oxygen | 1 | 2007 | 915 | 0.050 |
Why?
| | Airway Resistance | 1 | 2001 | 38 | 0.050 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2001 | 171 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2007 | 1269 | 0.040 |
Why?
| | Respiration, Artificial | 2 | 2001 | 613 | 0.040 |
Why?
| | Animals | 6 | 2007 | 35361 | 0.040 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1998 | 443 | 0.040 |
Why?
| | Up-Regulation | 2 | 1999 | 840 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1998 | 73 | 0.040 |
Why?
| | Estrogen Antagonists | 1 | 1997 | 45 | 0.040 |
Why?
| | Isoenzymes | 1 | 1998 | 302 | 0.030 |
Why?
| | RNA, Messenger | 3 | 1999 | 2708 | 0.030 |
Why?
| | Chronic Disease | 1 | 2001 | 1720 | 0.030 |
Why?
| | Transfection | 1 | 1997 | 911 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 1997 | 426 | 0.030 |
Why?
| | Nitric Oxide | 1 | 1999 | 902 | 0.030 |
Why?
| | Vasodilation | 1 | 1997 | 476 | 0.030 |
Why?
| | Cells, Cultured | 2 | 1999 | 4083 | 0.030 |
Why?
| | Fetus | 1 | 1997 | 773 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1998 | 821 | 0.030 |
Why?
| | Lung Diseases | 1 | 1998 | 742 | 0.020 |
Why?
| | Mice | 1 | 2007 | 16937 | 0.020 |
Why?
| | Lung | 1 | 1998 | 3930 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1999 | 69 | 0.010 |
Why?
| | Mutagens | 1 | 1999 | 17 | 0.010 |
Why?
| | Spermine | 1 | 1999 | 28 | 0.010 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 1999 | 48 | 0.010 |
Why?
| | Nitrogen Oxides | 1 | 1999 | 52 | 0.010 |
Why?
| | Immunoblotting | 1 | 1999 | 305 | 0.010 |
Why?
| | Cyclooxygenase 1 | 1 | 1998 | 26 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1999 | 811 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 958 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1998 | 177 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 1998 | 157 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 827 | 0.010 |
Why?
| | Gestational Age | 1 | 1998 | 874 | 0.010 |
Why?
| | Humans | 1 | 2007 | 129650 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1998 | 1065 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1998 | 1418 | 0.010 |
Why?
| | Time Factors | 1 | 1999 | 6556 | 0.000 |
Why?
| | Aging | 1 | 1998 | 1776 | 0.000 |
Why?
| | Pregnancy | 1 | 1998 | 6402 | 0.000 |
Why?
| | Female | 1 | 1998 | 68776 | 0.000 |
Why?
|
|
MacRitchie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|